These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 15184840

  • 21. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
    Henderson LS, Tenero DM, Baidoo CA, Campanile AM, Harter AH, Boyle D, Danoff TM.
    Am J Cardiol; 2006 Oct 02; 98(7A):17L-26L. PubMed ID: 17023228
    [Abstract] [Full Text] [Related]

  • 22. Development of a pharmacokinetic/pharmacodynamic model for carvedilol to predict beta1-blockade in patients with congestive heart failure.
    Tenero DM, Henderson LS, Campanile AM, Baidoo CA, Boyle D.
    Am J Cardiol; 2006 Oct 02; 98(7A):27L-31L. PubMed ID: 17023229
    [Abstract] [Full Text] [Related]

  • 23. COMET: a proposed mechanism of action to explain the results and concerns about dose.
    Coca SG, Buller GK.
    Lancet; 2003 Sep 27; 362(9389):1076; author reply 1077-8. PubMed ID: 14522541
    [No Abstract] [Full Text] [Related]

  • 24. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ, Yue TL, Cheng HY, Ruffolo RR.
    J Hypertens Suppl; 1993 Jun 27; 11(4):S41-8. PubMed ID: 8104241
    [Abstract] [Full Text] [Related]

  • 25. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
    Poole-Wilson PA.
    Am J Cardiol; 2004 May 06; 93(9A):40B-2B. PubMed ID: 15144936
    [Abstract] [Full Text] [Related]

  • 26. Carvedilol blockade of alpha1- and beta-adrenoceptor induced inotropic responses in rats with congestive heart failure.
    Qvigstad E, Sjaastad I, Bøkenes J, Schiander I, Solberg L, Sejersted OM, Osnes JB, Skomedal T.
    Eur J Pharmacol; 2005 May 23; 516(1):51-9. PubMed ID: 15916756
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
    Torp-Pedersen C, Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lutiger B, Metra M, Remme WJ, Scherhag A, Skene A, COMET Investigators.
    Am Heart J; 2005 Feb 23; 149(2):370-6. PubMed ID: 15846279
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effects of carvedilol on left ventricular function and arrhythmias during repeated short-time myocardial ischemia in experimental pigs.
    Höher M, Friedrich M, Sommer T, Marten A, Ehmer B, Hombach V, Hirche H.
    Z Kardiol; 1989 Feb 23; 78 Suppl 3():7-15. PubMed ID: 2573214
    [Abstract] [Full Text] [Related]

  • 33. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
    Barone FC, Nelson AH, Ohlstein EH, Willette RN, Sealey JE, Laragh JH, Campbell WG, Feuerstein GZ.
    J Pharmacol Exp Ther; 1996 Nov 23; 279(2):948-55. PubMed ID: 8930204
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Sudden cardiac death risk factors in patients with heart failure treated with carvedilol.
    Nessler J, Nessler B, Kitliński M, Libionka A, Kubinyi A, Konduracka E, Piwowarska W.
    Kardiol Pol; 2007 Dec 23; 65(12):1417-22; discussion 1423-4. PubMed ID: 18181053
    [Abstract] [Full Text] [Related]

  • 36. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
    Fowler MB.
    Eur Heart J; 1998 Dec 23; 19 Suppl P():P17-25. PubMed ID: 9886708
    [Abstract] [Full Text] [Related]

  • 37. Carvedilol.
    Frishman WH.
    Indian Heart J; 1999 Dec 23; 51(3):325-32. PubMed ID: 10624077
    [No Abstract] [Full Text] [Related]

  • 38. Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction.
    Kopecky SL.
    Am J Cardiol; 2006 Oct 15; 98(8):1115-9. PubMed ID: 17027583
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.